LMF2
Lipase maturation factor 2
Also known as: LMF2_HUMAN, TMEM112B, TMEM153
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BU23
- Gene
- LMF2
- Ensembl
- ENSG00000100258
- Chromosome
- 22
- Canonical length
- 707 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Centrosome
OverviewNCBI Gene
Predicted to be involved in protein maturation. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
707 residues, UniProt reviewed canonical sequence.
>Q9BU23|LMF2
1 MAGSRLPRQL FLQGVAAVFM FAFASLYTQI PGLYGPEGIL PARRTLRPQG KGRWQQLWET
61 PTLLWEAPRL GLDTAQGLEL LSLLGALVAL GALLLSPLRH PVIYLLLWAA YLSACQVGQV
121 FLYFQWDSLL LETGFLAVLV APLRPASHRK EAPQGRQAGA LPHEDLPFWL VRWLLFRLMF
181 ASGVVKLTSR CPAWWGLTAL TYHYETQCLP TPAAWFAHHL PVWLHKLSVV ATFLIEIAVP
241 PLFFAPIRRL RLAAFYSQVL LQVLIIITGN YNFFNLMTLV LTTALLDDQH LAAEPGHGSR
301 KKTATSWPKA LLATLSLLLE LAVYGLLAYG TVHYFGLEVD WQQRTIHSRT TFTFHQFSQW
361 LKTLTLPTVW LGVASLVWEL LSALWRWTQV RGWLRKLSAV VQLSLVGTAT VALFLISLVP
421 YSYVEPGTHG RLWTGAHRLF GAVEHLQLAN SYGLFRRMTG LGGRPEVVLE GSYDGHHWTE
481 IEFMYKPGNL SRPPPVVVPH QPRLDWQMWF AALGPHTHSP WFTSLVLRLL QGKEPVIRLV
541 QSQVARYPFH KQPPTYVRAQ RYKYWFSQPG EQGQWWRRQW VEEFFPSVSL GDPTLETLLR
601 QFGLQEKSPP RTRSANSTLA QALHWTRSQL SPLEAPALLW GLLMAVGAVR FVQALLAPCS
661 LRSSPLAPVS GEKRRPASQK DSGAASEQAT AAPNPCSSSS RTTRRKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LMF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 171 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 171 nTPM
- pituitary gland: 61 nTPM
- spleen: 58 nTPM
- thyroid gland: 54 nTPM
- liver: 54 nTPM
- prostate: 49 nTPM
Single-cell type
- extravillous trophoblasts: 138 nCPM
- oocytes: 111 nCPM
- cytotrophoblasts: 77 nCPM
- pancreatic acinar cells: 72 nCPM
- migrating cytotrophoblasts: 71 nCPM
- enterocytes: 67 nCPM
Immune cell
- plasmacytoid DC: 34 nTPM
- gdT-cell: 26 nTPM
- memory CD8 T-cell: 24 nTPM
- intermediate monocyte: 23 nTPM
- eosinophil: 22 nTPM
- memory CD4 T-cell: 22 nTPM
Brain region
- choroid plexus: 57 nTPM
- medulla oblongata: 40 nTPM
- hypothalamus: 36 nTPM
- white matter: 35 nTPM
- pons: 35 nTPM
- cerebral cortex: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.94
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.52
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LMF2 as an antibody target. Whether an autoantibody or antibody against LMF2 could matter depends on whether native LMF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LMF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LMF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...